AIDS vaccine Current Events | AIDS vaccine News | 7
|
| Page
7 of
48 |
958 Results |
|
|
|
Sort By:
Page Views | Date |
Combination vaccine protects monkeys from ebola and Marburg viruses
An experimental, combination vaccine against Ebola and Marburg viruses using virus-like particles (VLPs) provides complete protection against infection in monkeys. view more (2008-02-27)
AIDS And Tomatoes
Scientists from Novosibirsk are currently creating a pleasant and harmless vaccine - an edible one. So far, they managed to incorporate the protein gene - HIV antigen in tomatoes. The research is supported by International Science and Technology Center (ISTC). All patients would be overjoyed to get edible vaccines, contained in vegetables and... view more... (2004-07-19)
Vaccine shows promise for kidney cancer (pp 583, 594)
Results of a phase III study from Germany in this week's issue of THE LANCET suggest that a tumour-based vaccine could reduce disease recurrence and increase survival of patients who have had surgery for kidney cancer. 3% of cancer occurs in the kidney, with around 12,000 renal-cancer deaths a year in the USA. Removal of part or all of the kidney... view more... (2004-02-18)
Monitoring the response to vaccination against melanoma
A new study published in PLoS Medicine this week describes a way to measure the immune response in people treated with an experimental vaccine to melanoma. view more (2005-09-20)
How much is the world spending on neglected disease research and development?
The first comprehensive survey of global spending on neglected disease R&D, published in this week's PLoS Medicine, finds that just over $US 2.5 billion was invested into R&D of new products in 2007, with three diseases-HIV/AIDS, TB, and malaria-receiving nearly 80% of the total. view more (2009-02-04)
Timely Antiretroviral Therapy Essential For Best Prognosis In People With HIV-1 Infection (p 119)
Authors of an international study in this week's issue of THE LANCET highlight how timely treatment with highly-active antiretroviral therapy (HAART) can substantially improve the three-year prognosis for people with HIV-1 infection. HAART became widespread in more-developed countries in 1996. However, there is insufficient data from individual... view more... (2002-07-10)
Milestone biodefense publication by Elsevier journal Vaccine
Last week during the 'Vaccines for Biothreats and Emerging and Neglected Diseases Symposium' in Galveston TX, USA, the Elsevier journal Vaccine released a supplement dedicated to vaccines for biodefense. view more (2009-11-20)
Call for further study on meningococcal vaccine
Epidemiologist Dr Mahomed Patel said that an analysis of historical patterns of meningococcal incidence should also be examined to better understand, and further prevent, the bacterial infection. view more (2007-02-15)
In a crisis, creating DNA vaccine could help save lives, slow spread of 'bird flu'
Researchers scrambling to combat a virulent form of bird flu that could mutate into a form easily spread among humans should consider developing vaccines based on DNA, according to British biochemical engineers. view more (2005-10-20)
HIV-1 : RECOMBINATION BETWEEN TWO STRAINSFROM WIDELY DISTANT GROUPS
Scientists have known for a long time that the AIDS virus is genotypically highly variable. Two main types of the virus exist: HIV-1 and HIV-2. HIV-1, the most widespread throughout the world, can be divided into three groups (M, N and O) each of which has different genetic characteristics. Within group M, which gathers together the most frequent... view more... (2000-03-09)
Research holds promise for herpes vaccine
A study by a Montana State University researcher suggests a new avenue for developing a vaccine against genital herpes and other diseases caused by herpes simplex viruses. view more (2006-10-16)
Safe vaccine to combat herpes infections
The unpleasant and painful sores, and infection of newborn babies caused by the genital herpes virus could soon be a thing of the past according to Dr Julian Hickling, who is presenting results from Xenova Research Ltd today, Tuesday 8 April 2003, to the Society for General Microbiology's Spring Meeting in Edinburgh. "The challenge is trying... view more... (2003-04-02)
Meningococcal C Vaccine Could Increase Relapse For Children With Kidney Disease (p 449)
Withholding meningococcal vaccine could be the best strategy for children with the kidney disorder nephrotic syndrome, according to authors of a research letter in this week's issue of THE LANCET. In November, 1999, all children under 18 years of age in the UK were offered immunisation with the newly introduced meningococcal C conjugate vaccine... view more... (2003-08-06)
STEP HIV vaccine study to be unblinded
Merck & Co., Inc. and the HIV Vaccine Trials Network (HVTN) today announced that study volunteers in the STEP study of Merck's HIV vaccine (V520) will be told whether they received vaccine or placebo, and all study volunteers will be encouraged to continue to return to their study sites on a regular basis for ongoing risk reduction counseling... view more... (2007-11-14)
Duke To Test Bird Flu Vaccine Dosing
A clinical trial to test different strengths of a vaccine designed to fight avian influenza will begin this month at Duke University Medical Center. view more (2006-03-31)
Bird flu vaccine additive may stretch supply
Researchers have achieved an effective immune response to an avian influenza vaccine with doses as low as one-quarter of the norm when they added a chemical mixture known as MF59. view more (2006-09-26)
Smallpox Outbreak: How Long Would It Take for Vaccines To Protect People? Would it Work?
In the event of a smallpox outbreak in the United States, how long would it take for a vaccine to start protecting Americans by stimulating an immune response? A new national study led by Saint Louis University School of Medicine will attempt to answer this question. view more (2007-05-01)
New vaccine shows promise for COPD patients at risk for pneumonia
A new vaccine against pneumonia may offer better protection from chronic obstructive pulmonary disease (COPD) patients than the currently accepted vaccine, according to recent research that will be published in the September 15 issue of the American Journal of the Respiratory and Critical Care Journal, a publication of the American Thoracic... view more... (2009-09-08)
Experimental vaccine protects lab animals against several strains of H5N1
Nations are preparing to stockpile vaccines against H5N1, the strain of influenza virus that experts fear could cause the next flu pandemic. But will these vaccines remain effective as the virus mutates? view more (2006-06-14)
MSU study finds that not all hearing aids are created equal
Consumers with hearing loss might think they are saving significantly more by purchasing over- the-counter hearing aids, but they most likely will be disappointed - or could be taking risks - when purchasing such aids, according to MSU research. view more (2008-08-14)
|
|
| Page
7 of
48 |
958 Results |
|
|
|
Sort By:
Page Views | Date |
|
